GLP3-RT (Retatrutide)
$279
For research use only. Not for human or veterinary consumption.
Quantity
Bundle & Save
Retatrutide 30mg, 20mg, 10mg or 6mg — Research Compound
- Premium Quality, Fast Shipping
- Many researchers start with a dose of 1mg-2mg per week.
- Target dosing of 4mg-5mg per week.
Retatrutide is a multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors, developed for the treatment of obesity and type 2 diabetes.
By simultaneously modulating these three pathways, Retatrutide provides a comprehensive metabolic approach, promoting weight loss, glycemic control, improved lipid metabolism, and enhanced energy expenditure. Its once- weekly subcutaneous administration improves patient adherence while maintaining therapeutic efficacy.
Mechanism of Action:
- GLP-1 receptor activation: Stimulates glucose- dependent insulin secretion, suppresses appetite, and improves glycemic control.
- GIP receptor activation: Enhances insulin response and supports fat metabolism.
- Glucagon receptor activation: Increases energy expenditure and promotes fatty acid oxidation.
- Synergistic effects: Dual and triple receptor engagement provides superior weight loss, cardiometabolic benefits, and metabolic flexibility compared to single-agent therapies.
Benefits May Include:
- Weight Loss: Up to 24% body weight reduction in clinical trials; targets visceral fat
- Glycemic Control: HbA1c reduction up to 2.2%; improves glucose homeostasis and insulin sensitivity
- Energy Expenditure: Promotes thermogenesis and fatty acid oxidation through glucagon receptor activity
- Appetite Regulation: Enhanced satiety and reduced caloric intake via GLP-1 and GIP pathways
- Cardiovascular Health: Reduces triglycerides, improves lipid profile, lowers systolic blood pressure
- Fat Loss & Body Composition: Preferential visceral fat reduction; maintains lean mass
- Metabolic Flexibility: Optimizes glucose and lipid metabolism for overall metabolic health
- Sustained Efficacy: Once-weekly dosing supports long- term adherence and durable metabolic effects
Specifications:
- Compound: Retatrutide
- Format: Research compound
- Use: Research use only
Order before the 2 PM EST cutoff for same-day processing
Cutoff 2 PM EST Mon–Fri, 12 PM EST Sat–Sun
Shipping protection available
Overnight shipping available
Free shipping
on orders over $100
Shipping protection
optional add-on at checkout
Secure checkout
256-bit SSL
Certificate of Analysis
Third Party Tested · ISO/IEC 17025 Accredited
7×
Testing
Passed full QC panel
- Variant
- GLP3-RT (Retatrutide)
- Lot #
- —
- Category
- Women's Health Research
- Tested
- Oct 5, 2026
ISO/IEC 17025 Accredited
Compound Information
Technical specifications
What is GLP3-RT (Retatrutide)?
- Type
- Synthetic compound
- Category
- Women's Health Research
- Form
- Lyophilized powder
- Lot
- —
Frequently Researched Together
Commonly studied alongside this compound
Important Research Notice
Not for human consumption. This product is sold exclusively as a research reagent for in vitro and laboratory use by qualified researchers. It is not a drug, supplement, or cosmetic, is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease. No dosing, administration, or benefit claims are made or implied.
Published literature referenced on this page describes third-party studies of the compound class and is provided for scientific context only. It is not a claim about this product and not evidence of safety or efficacy in any organism.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
All the research compounds you need, with the peace of mind and research community at your fingertips.
Shop NowResearch updates from Elite Performance Research
Subscribe for catalog updates, new research compounds, and quality documentation news.
For researchers and labs. No spam, unsubscribe anytime.